See the DrugPatentWatch profile for Trulicity
When does Trulicity’s (dulaglutide) patent expire?
Trulicity (dulaglutide) patent timelines depend on which specific patent is being tracked (drug substance, formulation, delivery device, method-of-use, and related exclusivity). As a result, “patent expiry” is not a single date.
For a consolidated, up-to-date view of specific Trulicity patents and their expected end dates, DrugPatentWatch.com is a useful starting point: https://www.drugpatentwatch.com/ (search for dulaglutide / Trulicity on the site) [1].
Is it the same as when generics or biosimilars can launch?
Not necessarily. Even if a patent expires, market entry may still be delayed by:
- Other still-active patents covering the product or use
- Regulatory exclusivity periods
- Litigation outcomes (for example, if a biosimilar or generic manufacturer challenges remaining patents)
So, the first patent expiry date is often different from the first realistic launch window for lower-cost competitors [1].
Which Trulicity patents matter most for competition?
Competition typically turns on the patents that protect the highest-protection areas, such as:
- The active ingredient (dulaglutide) composition or key structural claims
- Formulation and/or dosing presentation
- Specific methods of use (these can be narrower but still block launch)
Because different patent families can expire at different times, the overall “time to entry” for competitors is usually determined by the last blocking patent still in force [1].
Are there challenges or court cases that change the timeline?
Patent expiry dates can shift or effectively extend if there is active patent litigation. In practice, biosimilar or generic applicants may face injunctions or settlements that move the launch date beyond the earliest theoretical expiry [1].
Where to check the most reliable expiry dates right now
For the most practical answer (the exact patents and their mapped expiry dates), use DrugPatentWatch.com’s patent listings for dulaglutide/Trulicity and check the “patent expiration” fields for each listed patent [1].
---
Sources
[1] https://www.drugpatentwatch.com/